
|Articles|May 27, 2020
ASCRS 2020: Evaluation of intraoperative use of DEXYCU on signs/symptoms of dry eye
Author(s)Alex Delaney-Gesing
Advertisement
Sanjay N. Rao, MD, director of Refractive, Cornea and Advanced Anterior Segment Surgery at Dekalb Eye Consultants LLC, speaks with Ophthalmology Times' David Hutton on his presentation "Evaluation of intraoperative use of dexamethasone intraocular suspension, 9% (DEXYCU) on signs and symptoms of dry eye," during the 2020 ASCRS virtual conference.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
How AI is reshaping ophthalmology in 2025 and beyond
2
Glaucoma 2026: Which emerging technologies will change practice?
3
The year in optometry: 10 stories that defined eye care in 2025
4
Refractory dry eye care: How systemic conditions change the game
5












































